

Instance: composition-en-f37dc8b0ce387c50af638cbc7ed30e60
InstanceOf: CompositionUvEpi
Title: "Composition for forsteo Package Leaflet"
Description:  "Composition for forsteo Package Leaflet"
Usage: #inline

* identifier.system = ""

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mock)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - forsteo"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  What is in this leaflet:  
1. What FORSTEO is and what it is used for 
2. What you need to know before you use FORSTEO 
3. How to use FORSTEO 
4. Possible side effects 
5. How to store FORSTEO 
6. Content of the pack and other information          </div>"""   
          

* section[=].section[+]
  * title =  "1. What forsteo is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What forsteo is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>FORSTEO contains the active substance teriparatide that is used to make the bones stronger, and to 
reduce the risk of fractures by stimulating bone formation. </p>
<p>FORSTEO is used to treat osteoporosis in adults. Osteoporosis is a disease that causes your bones to 
become thin and fragile. This disease is especially common in women after the menopause, but it can 
also occur in men. Osteoporosis is also common in patients receiving corticosteroids. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take forsteo"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take forsteo"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not use FORSTEO<br />
<em> if you are allergic to teriparatide or any of the other ingredients of this medicine (listed in 
section 6). 
* if you suffer from high calcium levels (pre-existing hypercalcaemia). 
* if you suffer from serious kidney problems. 
* if you have ever been diagnosed with bone cancer or other cancers that have spread 
(metastasised) to your bones.<br />
</em> if you have certain bone diseases. If you have a bone disease, tell your doctor.<br />
<em> if you have unexplained high levels of alkaline phosphatase in your blood, which means you 
might have Paget s disease of bone (disease with abnormal bone changes). If you are not sure, 
ask your doctor.<br />
</em> if you have had radiation therapy involving your bones. 
* if you are pregnant or breast-feeding. </p>
<p>Warnings and precautions 
FORSTEO may cause an increase in the amount of calcium in your blood or urine. </p>
<p>Talk to your doctor or pharmacist before or while using FORSTEO:  </p>
<ul>
<li>if you have continuing nausea, vomiting, constipation, low energy, or muscle weakness. These 
may be signs there is too much calcium in your blood.   </li>
<li>if you suffer from kidney stones or have a history of kidney stones.  </li>
<li>if you suffer from kidney problems (moderate renal impairment). </li>
</ul>
<p>Some patients get dizzy or get a fast heartbeat after the first few doses. For the first doses, inject 
FORSTEO where you can sit or lie down right away if you get dizzy. </p>
<p>The recommended treatment time of 24 months should not be exceeded. </p>
<p>FORSTEO should not be used in growing adults. </p>
<p>Children and adolescents 
FORSTEO should not be used in children and adolescents (less than 18 years). </p>
<p>Other medicines and FORSTEO 
Please tell your doctor or pharmacist if you are taking, have recently taken or might take any other 
medicines, because occasionally they may interact (e.g. digoxin/digitalis, a medicine used to treat heart 
disease). </p>
<p>Pregnancy and breast-feeding 
Do not use FORSTEO if you are pregnant or breast-feeding. If you are a woman of child-bearing 
potential, you should use effective methods of contraception during use of FORSTEO.  If you become 
pregnant, FORSTEO should be discontinued. Ask your doctor or pharmacist for advice before taking 
any medicine. </p>
<p>Driving and using machines 
Some patients may feel dizzy after injecting FORSTEO. If you feel dizzy you should not drive or use 
machines until you feel better. </p>
<p>FORSTEO contains sodium 
This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially  sodium-
free . </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take forsteo"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take forsteo"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always use this medicine exactly as your doctor has told you to. Check with your doctor or pharmacist 
if you are not sure. </p>
<p>The recommended dose is 20 micrograms given once daily by injection under the skin (subcutaneous 
injection) in the thigh or abdomen. To help you remember to take your medicine, inject it at about the 
same time each day. </p>
<p>Inject FORSTEO each day for as long as your doctor prescribes it for you. The total duration of 
treatment with FORSTEO should not exceed 24 months. You should not receive more than one 
treatment course of 24 months over your lifetime. </p>
<p>FORSTEO can be injected at meal times. </p>
<p>Read the user manual booklet, which is included in the carton for instructions on how to use the 
FORSTEO pen.  </p>
<p>Injection needles are not included with the pen. Becton, Dickinson and Company pen needles can be 
used. </p>
<p>You should take your FORSTEO injection shortly after you take the pen out of the refrigerator as 
described in the user manual. Put the pen back into the refrigerator immediately after you have used it. 
Use a new injection needle for each injection and dispose of it after each use. Never store your pen 
with the needle attached. Never share your FORSTEO pen with others. </p>
<p>Your doctor may advise you to take FORSTEO with calcium and vitamin D. Your doctor will tell you 
how much you should take each day.  </p>
<p>FORSTEO can be given with or without food. </p>
<p>If you use more FORSTEO than you should 
If, by mistake, you have used more FORSTEO than you should, contact your doctor or pharmacist.  </p>
<p>The effects of overdose that might be expected include nausea, vomiting, dizziness, and headache. </p>
<p>If you forget or cannot take FORSTEO at your usual time, take it as soon as possible on that day. 
Do not take a double dose to make up for a forgotten dose. Do not take more than one injection in the 
same day. Do not try to make up for a missed dose. </p>
<p>If you stop taking FORSTEO 
If you are considering stopping FORSTEO treatment, please discuss this with your doctor. Your 
doctor will advise you and decide how long you should be treated with FORSTEO. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>The most common side effects are pain in limb (frequency is very common, may affect more than 1 in 
10 people) and feeling sick, headache and dizziness (frequency is common). If you become dizzy 
(light-headed) after your injection, you should sit or lie down until you feel better. If you do not feel 
better, you should call a doctor before you continue treatment. Cases of fainting have been reported in 
association with teriparatide use. </p>
<p>If you experience discomfort such as redness of the skin, pain, swelling, itching, bruising or minor 
bleeding around the area of the injection (frequency is common), this should clear up in a few days or 
weeks. Otherwise tell your doctor as soon as possible. </p>
<p>Some patients may have experienced allergic reactions soon after injection, consisting of 
breathlessness, swelling of the face, rash and chest pain (frequency is rare). In rare cases, serious and 
potentially life-threatening allergic reactions including anaphylaxis can occur. </p>
<p>Other side effects include: 
Common: may affect up to 1 in 10 people 
* increase in blood cholesterol levels 
* depression 
* neuralgic pain in the leg 
* feeling faint 
* irregular heart beats 
* breathlessness 
* increased sweating 
* muscle cramps 
* loss of energy </p>
<ul>
<li>tiredness </li>
<li>chest pain </li>
<li>low blood pressure  </li>
<li>heartburn (painful or burning sensation just below the breast bone)  </li>
<li>being sick(vomiting) </li>
<li>a hernia of the tube that carries food to your stomach  </li>
<li>low haemoglobin or red blood cell count (anaemia) </li>
</ul>
<p>Uncommon: may affect up to 1 in 100 people<br />
<em> increased heart rate 
* abnormal heart sound<br />
</em> shortness of breath<br />
<em> haemorrhoids (piles) 
* accidental loss or leakage of urine<br />
</em> increased need to pass water<br />
* weight increase 
* kidney stones 
* pain in the muscles and pain in the joints. Some patients have experienced severe back cramps 
or pain which lead to hospitalisation. 
* increase in blood calcium level 
* increase in blood uric acid level 
* increase in an enzyme called alkaline phosphatase. </p>
<p>Rare: may affect up to 1 in 1,000 people <br />
* reduced kidney function, including renal failure 
* swelling, mainly in the hands, feet and legs. </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects 
not listed in this leaflet. You can also report side effects directly via the national reporting system 
listed in Appendix V. By reporting side effects you can help provide more information on the safety of 
this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store forsteo"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store forsteo"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the carton and pen after EXP. The 
expiry date refers to the last day of that month. </p>
<p>FORSTEO should be stored in a refrigerator (2 C to 8 C) at all times. You can use FORSTEO for up 
to 28 days after the first injection, as long as the pen is stored in a refrigerator (2 C to 8 C). </p>
<p>Do not freeze FORSTEO. Avoid placing the pens close to the ice compartment of the refrigerator to 
prevent freezing. Do not use FORSTEO if it is, or has been, frozen. </p>
<p>Each pen should be properly disposed of after 28 days, even if it is not completely empty. </p>
<p>FORSTEO contains a clear and colourless solution. Do not use FORSTEO if solid particles appear or 
if the solution is cloudy or coloured.  </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use These measures will help to protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What FORSTEO contains 
- The active substance is teriparatide. Each millilitre of the solution for injection contains 
250 micrograms of teriparatide. 
- The other ingredients are glacial acetic acid, sodium acetate (anhydrous), mannitol, metacresol, 
and water for injections. In addition, hydrochloric acid and/or sodium hydroxide solution may 
have been added for pH adjustment. </p>
<p>What FORSTEO looks like and contents of the pack 
FORSTEO is a colourless and clear solution. It is supplied in a cartridge contained in a pre-filled 
disposable pen. Each pen contains 2.4 mL of solution enough for 28 doses. The pens are available in 
cartons containing one or three pens. Not all pack sizes may be available. </p>
<p>Marketing Authorisation Holder<br />
Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands </p>
<p>Manufacturer 
Lilly France S.A.S, Rue du Colonel Lilly, F-67640 Fegersheim, France. </p>
<p>For any information about this medicine, please contact the local representative of the Marketing 
Authorisation Holder. </p>
<p>Belgi /Belgique/Belgien 
Eli Lilly Benelux S.A./N.V. 
T l/Tel: + 32 (0) 2 548 84 Lietuva 
Eli Lilly Lietuva 
Tel: + 370 (5) 2649<br />
  "     "  . . - <br />
 : + 359 2 491 41 Luxembourg/Luxemburg 
Eli Lilly Benelux S.A./N.V. 
T l/Tel: + 32 (0) 2 548 84 84<br />
 esk  republika 
Eli Lilly  R, s.r.o. 
Tel: + 420 234 664 Magyarorsz g 
Lilly Hung ria Kft. 
Tel: + 36 1 328 5Danmark 
Eli Lilly Danmark A/S 
Tlf: + 45 45 26 60 Malta 
Charles de Giorgio Ltd. 
Tel: + 356 25600 Deutschland 
Lilly Deutschland GmbH 
Tel: + 49 (0) 6172 273 2Nederland 
Eli Lilly Nederland B.V. 
Tel: + 31(0) 30 6025Eesti 
Eli Lilly Nederland B.V. <br />
Tel: +372 6 817 Norge 
Eli Lilly Norge A.S 
Tlf: + 47 22 88 18  a 
 -   . . . . 
 : + 30 210 629 4 sterreich 
Eli Lilly Ges. m.b.H.<br />
Tel: + 43 (0) 1 711 Espa a 
  Valquifarma, S.A.U.<br />
  Tel: + 34-91 623 1Polska 
Eli Lilly Polska Sp. z o.o. 
Tel: + 48 22 440 33 France 
Lilly France 
T l: + 33 (0) 1 55 49 34 Portugal 
Lilly Portugal Produtos Farmac uticos, Lda 
Tel: + 351 21 412 66 Hrvatska 
Eli Lilly Hrvatska d.o.o. 
Tel: +385 1 2350 Rom nia 
Eli Lilly Rom nia S.R.L. 
Tel: + 40 21 4023Ireland 
Eli Lilly and Company (Ireland) Limited 
Tel: + 353 (0) 1 661 4Slovenija 
Eli Lilly farmacevtska dru ba, d.o.o. 
Tel: + 386 (0) 1 580 00  </p>
<p>sland 
Icepharma hf. 
S mi: + 354 540 8Slovensk  republika 
Eli Lilly Slovakia s.r.o. 
Tel: + 421 220 663 Italia 
Eli Lilly Italia S.p.A. 
Tel: + 39 055 42Suomi/Finland 
Oy Eli Lilly Finland Ab 
Puh/Tel: + 358 (0) 9 8545 <br />
Phadisco Ltd<br />
 : + 357 22 715Sverige 
Eli Lilly Sweden AB 
Tel: + 46 (0) 8 7378Latvija 
Eli Lilly (Suisse) S.A P rst vniec ba Latvij <br />
Tel: + 371 67364United Kingdom (Northern Ireland) 
Eli Lilly and Company (Ireland) Limited 
Tel: + 353-(0) 1 661 4 </p>
<p>This leaflet was last revised in  </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      

